EFSA/FDA agreement to facilitate scientific co-operation - Brussels, 2 July 2007
28 Juni 2007
On 2 July, the first formal step to enhance co-operation between the US Food and Drug Administration (FDA) and EFSA will be taken.
Andrew C. von Eschenbach, Commissioner of the US FDA and Catherine Geslain-Lanéelle, EFSA's Executive Director, will meet to discuss about current and future co-operation between the two agencies and to sign an agreement which will facilitate the sharing of scientific information.
The meeting, between the representatives of EFSA and FDA, will take place from 16.00 until 16.45 pm in Brussels, Renaissance Hotel, Rue de Parnasse, 19. His Excellency, Mr. C. Boyden Gray, Ambassador of the United States of America to the EU will be present at the meeting.
Programme
Renaissance Hotel
Room: Montreux 3
Rue de Parnasse, 19 – 1050 Brussels
16.00 – 16.45 Meeting between FDA and EFSA representatives:
- Welcome and introductions
- Review of current co-operation between our agencies
- Discuss possibility of further co-operation
16.45 Signing of the Statement on Confidentiality Arrangements between FDA and EFSA and photo opportunity
16.45 – 17.00 Questions & Answers
To register please send an email with your contact details to the following address: press@efsa.europa.eu
Für Medienanfragen wenden Sie sich bitte an:
Medienstelle der EFSA
Tel. +39 0521 036 149
E-Mail: Press@efsa.europa.eu
